Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:53 pm
| PEG Ratio | -6.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mahickra Chemicals Ltd operates in the Dyes & Pigments industry and reported a current stock price of ₹150, with a market capitalization of ₹121 Cr. The company’s revenue has experienced fluctuations over the past few years, with sales standing at ₹103.01 Cr for the fiscal year ending March 2023, a slight increase from ₹102.28 Cr in the previous year. However, the TTM sales for the latest period are reported at ₹92.41 Cr, indicating a downward trend in revenue generation. Quarterly sales figures show variability, with the highest recorded at ₹59.90 Cr in March 2022, followed by a decline to ₹49.15 Cr in March 2023 and further down to ₹37.21 Cr in September 2023. This inconsistency in revenue generation raises concerns about market demand and operational efficiency, especially given the competitive landscape of the industry where consistent performance is crucial for sustainability.
Profitability and Efficiency Metrics
Profitability metrics for Mahickra Chemicals reflect the company’s struggle to maintain a strong operating profit margin, which stood at just 3.00%. In the fiscal year March 2023, the net profit was recorded at ₹3.28 Cr, translating into an EPS of ₹4.04. The company’s operating profit margin (OPM) has shown fluctuations, with a low of 0.33% in March 2022 and a peak of 3.70% in March 2023, demonstrating volatility in cost management and pricing strategies. The interest coverage ratio (ICR) is reported at 3.96x, indicating that the company can cover its interest obligations comfortably, which is a positive sign. However, the cash conversion cycle (CCC) of 182.37 days suggests inefficiencies in working capital management, particularly in inventory and receivables management, which can adversely affect liquidity and operational agility.
Balance Sheet Strength and Financial Ratios
Mahickra Chemicals has a balance sheet characterized by total borrowings of ₹14.90 Cr against reserves of ₹28.48 Cr, reflecting a reasonable level of debt relative to equity. The total liabilities stood at ₹71.37 Cr, while total assets were reported at the same amount, indicating a balanced approach to asset financing. The company’s return on equity (ROE) is recorded at 7.33%, which is relatively low, suggesting that the firm is not generating a high return on shareholders’ investments compared to industry norms. The price-to-book value (P/BV) ratio is noted at 2.85x, indicating that the stock may be overvalued, depending on market perceptions. With a current ratio of 1.92, Mahickra Chemicals appears to be in a satisfactory position to meet its short-term liabilities, although the quick ratio of 0.93 raises concerns about immediate liquidity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mahickra Chemicals indicates a stable yet cautious investor environment. Promoters hold 48.27% of the shares, with a gradual decline from 54.95% in March 2024, suggesting a potential dilution of control or a strategic shift. The public holds 51.73%, which reflects a significant retail investor base. Notably, foreign institutional investors (FIIs) hold 0.00%, and domestic institutional investors (DIIs) also hold 0.00%, indicating a lack of institutional confidence in the company’s prospects. The number of shareholders has increased to 355, showing growing interest, albeit without institutional backing. This mix of ownership may suggest a reliance on retail investors, which can be volatile and may affect stock price stability in the long run.
Outlook, Risks, and Final Insight
Looking ahead, Mahickra Chemicals faces both opportunities and risks. The company can capitalize on potential growth in the dyes and pigments sector, driven by increasing demand from textile and manufacturing industries. However, challenges such as fluctuating raw material costs, regulatory pressures, and intense competition could impede profitability. The significant cash conversion cycle indicates that improving operational efficiency should be a priority to enhance liquidity and reduce working capital requirements. The company’s relatively low ROE and the high P/BV ratio may deter potential investors unless performance improves. If Mahickra Chemicals can streamline its operations and effectively manage costs, it could enhance its profitability and attract institutional investors, potentially stabilizing its share price and boosting market confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 36.8 Cr. | 121 | 190/68.5 | 20.2 | 162 | 0.82 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 45.8 Cr. | 76.2 | 281/68.5 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 833 Cr. | 674 | 1,148/432 | 21.5 | 91.7 | 0.15 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,687 Cr. | 338 | 570/272 | 35.0 | 62.2 | 1.48 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 60.1 Cr. | 53.5 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,363.62 Cr | 304.17 | 94.26 | 186.93 | 0.39% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.69 | 44.59 | 33.69 | 52.83 | 42.40 | 59.90 | 53.88 | 49.15 | 37.21 | 34.70 | 44.79 | 43.36 | 49.05 |
| Expenses | 49.09 | 44.61 | 32.71 | 51.70 | 40.88 | 59.70 | 53.39 | 47.33 | 35.69 | 35.55 | 42.49 | 43.17 | 47.58 |
| Operating Profit | 0.60 | -0.02 | 0.98 | 1.13 | 1.52 | 0.20 | 0.49 | 1.82 | 1.52 | -0.85 | 2.30 | 0.19 | 1.47 |
| OPM % | 1.21% | -0.04% | 2.91% | 2.14% | 3.58% | 0.33% | 0.91% | 3.70% | 4.08% | -2.45% | 5.14% | 0.44% | 3.00% |
| Other Income | 2.42 | 1.93 | 0.90 | 2.08 | 1.26 | 2.67 | 2.46 | 1.25 | 0.03 | 2.24 | 0.34 | 2.29 | 0.75 |
| Interest | 0.32 | 0.37 | 0.33 | 0.24 | 0.35 | 0.40 | 0.48 | 0.42 | 0.58 | 0.58 | 0.68 | 0.61 | 0.73 |
| Depreciation | 0.04 | 0.06 | 0.05 | 0.06 | 0.11 | 0.14 | 0.24 | 0.31 | 0.28 | 0.00 | 0.15 | 0.15 | 0.16 |
| Profit before tax | 2.66 | 1.48 | 1.50 | 2.91 | 2.32 | 2.33 | 2.23 | 2.34 | 0.69 | 0.81 | 1.81 | 1.72 | 1.33 |
| Tax % | 33.83% | 16.22% | 29.33% | 28.87% | 28.45% | 27.90% | 28.70% | 27.35% | 28.99% | 28.40% | 25.41% | 30.81% | 31.58% |
| Net Profit | 1.75 | 1.25 | 1.05 | 2.06 | 1.67 | 1.68 | 1.59 | 1.70 | 0.49 | 0.58 | 1.35 | 1.19 | 0.91 |
| EPS in Rs | 2.42 | 1.54 | 1.29 | 2.54 | 2.06 | 2.07 | 1.96 | 2.09 | 0.60 | 0.71 | 1.66 | 1.47 | 1.12 |
Last Updated: December 30, 2025, 2:37 am
Below is a detailed analysis of the quarterly data for Mahickra Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 49.05 Cr.. The value appears strong and on an upward trend. It has increased from 43.36 Cr. (Mar 2025) to 49.05 Cr., marking an increase of 5.69 Cr..
- For Expenses, as of Sep 2025, the value is 47.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.17 Cr. (Mar 2025) to 47.58 Cr., marking an increase of 4.41 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.47 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 1.47 Cr., marking an increase of 1.28 Cr..
- For OPM %, as of Sep 2025, the value is 3.00%. The value appears strong and on an upward trend. It has increased from 0.44% (Mar 2025) to 3.00%, marking an increase of 2.56%.
- For Other Income, as of Sep 2025, the value is 0.75 Cr.. The value appears to be declining and may need further review. It has decreased from 2.29 Cr. (Mar 2025) to 0.75 Cr., marking a decrease of 1.54 Cr..
- For Interest, as of Sep 2025, the value is 0.73 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.61 Cr. (Mar 2025) to 0.73 Cr., marking an increase of 0.12 Cr..
- For Depreciation, as of Sep 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.15 Cr. (Mar 2025) to 0.16 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.33 Cr.. The value appears to be declining and may need further review. It has decreased from 1.72 Cr. (Mar 2025) to 1.33 Cr., marking a decrease of 0.39 Cr..
- For Tax %, as of Sep 2025, the value is 31.58%. The value appears to be increasing, which may not be favorable. It has increased from 30.81% (Mar 2025) to 31.58%, marking an increase of 0.77%.
- For Net Profit, as of Sep 2025, the value is 0.91 Cr.. The value appears to be declining and may need further review. It has decreased from 1.19 Cr. (Mar 2025) to 0.91 Cr., marking a decrease of 0.28 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.12. The value appears to be declining and may need further review. It has decreased from 1.47 (Mar 2025) to 1.12, marking a decrease of 0.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:01 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.52 | 80.02 | 94.28 | 86.49 | 102.28 | 103.01 | 71.92 | 88.16 | 92.41 |
| Expenses | 18.75 | 78.98 | 93.70 | 84.38 | 100.53 | 100.59 | 71.25 | 85.66 | 90.75 |
| Operating Profit | 0.77 | 1.04 | 0.58 | 2.11 | 1.75 | 2.42 | 0.67 | 2.50 | 1.66 |
| OPM % | 3.94% | 1.30% | 0.62% | 2.44% | 1.71% | 2.35% | 0.93% | 2.84% | 1.80% |
| Other Income | 0.46 | 2.47 | 4.35 | 2.98 | 3.93 | 3.62 | 2.27 | 2.62 | 3.04 |
| Interest | 0.24 | 0.53 | 0.69 | 0.57 | 0.78 | 0.93 | 1.16 | 1.29 | 1.34 |
| Depreciation | 0.05 | 0.07 | 0.10 | 0.12 | 0.25 | 0.55 | 0.28 | 0.30 | 0.31 |
| Profit before tax | 0.94 | 2.91 | 4.14 | 4.40 | 4.65 | 4.56 | 1.50 | 3.53 | 3.05 |
| Tax % | 21.28% | 29.90% | 27.54% | 29.55% | 27.74% | 27.85% | 28.67% | 28.33% | |
| Net Profit | 0.74 | 2.04 | 2.99 | 3.11 | 3.35 | 3.28 | 1.07 | 2.53 | 2.10 |
| EPS in Rs | 1.44 | 2.82 | 3.68 | 3.83 | 4.12 | 4.04 | 1.32 | 3.11 | 2.59 |
| Dividend Payout % | 0.00% | 0.00% | 8.15% | 5.22% | 15.76% | 16.09% | 22.77% | 6.42% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 175.68% | 46.57% | 4.01% | 7.72% | -2.09% | -67.38% | 136.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | -129.11% | -42.56% | 3.70% | -9.81% | -65.29% | 203.83% |
Mahickra Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | -5% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | -9% |
| TTM: | 136% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 29% |
| 1 Year: | 37% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 7% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 10:15 am
Balance Sheet
Last Updated: December 10, 2025, 3:02 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.13 | 7.23 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 |
| Reserves | 2.64 | 7.84 | 15.86 | 18.81 | 21.63 | 24.37 | 25.20 | 27.57 | 28.48 |
| Borrowings | 6.34 | 4.80 | 5.55 | 10.56 | 10.02 | 10.08 | 13.44 | 15.30 | 14.90 |
| Other Liabilities | 20.50 | 23.23 | 20.90 | 20.21 | 25.39 | 20.91 | 14.02 | 17.28 | 19.87 |
| Total Liabilities | 34.61 | 43.10 | 50.43 | 57.70 | 65.16 | 63.48 | 60.78 | 68.27 | 71.37 |
| Fixed Assets | 0.67 | 0.79 | 0.85 | 0.96 | 1.68 | 4.48 | 4.59 | 5.15 | 5.02 |
| CWIP | -0.00 | -0.00 | 2.15 | 2.56 | 2.93 | 0.43 | 0.70 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.05 | 0.05 | 0.05 | 0.05 |
| Other Assets | 33.94 | 42.31 | 47.43 | 54.18 | 60.55 | 58.52 | 55.44 | 63.07 | 66.30 |
| Total Assets | 34.61 | 43.10 | 50.43 | 57.70 | 65.16 | 63.48 | 60.78 | 68.27 | 71.37 |
Below is a detailed analysis of the balance sheet data for Mahickra Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.12 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.12 Cr..
- For Reserves, as of Sep 2025, the value is 28.48 Cr.. The value appears strong and on an upward trend. It has increased from 27.57 Cr. (Mar 2025) to 28.48 Cr., marking an increase of 0.91 Cr..
- For Borrowings, as of Sep 2025, the value is 14.90 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 15.30 Cr. (Mar 2025) to 14.90 Cr., marking a decrease of 0.40 Cr..
- For Other Liabilities, as of Sep 2025, the value is 19.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.28 Cr. (Mar 2025) to 19.87 Cr., marking an increase of 2.59 Cr..
- For Total Liabilities, as of Sep 2025, the value is 71.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 68.27 Cr. (Mar 2025) to 71.37 Cr., marking an increase of 3.10 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5.02 Cr.. The value appears to be declining and may need further review. It has decreased from 5.15 Cr. (Mar 2025) to 5.02 Cr., marking a decrease of 0.13 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.05 Cr..
- For Other Assets, as of Sep 2025, the value is 66.30 Cr.. The value appears strong and on an upward trend. It has increased from 63.07 Cr. (Mar 2025) to 66.30 Cr., marking an increase of 3.23 Cr..
- For Total Assets, as of Sep 2025, the value is 71.37 Cr.. The value appears strong and on an upward trend. It has increased from 68.27 Cr. (Mar 2025) to 71.37 Cr., marking an increase of 3.10 Cr..
Notably, the Reserves (28.48 Cr.) exceed the Borrowings (14.90 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.57 | -3.76 | -4.97 | -8.45 | -8.27 | -7.66 | -12.77 | -12.80 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 312.83 | 107.69 | 106.04 | 142.94 | 135.96 | 130.29 | 119.16 | 105.78 |
| Inventory Days | 212.44 | 42.23 | 48.98 | 70.98 | 72.06 | 77.95 | 143.12 | 149.95 |
| Days Payable | 416.27 | 111.00 | 83.18 | 89.26 | 97.69 | 76.52 | 71.90 | 73.36 |
| Cash Conversion Cycle | 109.00 | 38.93 | 71.84 | 124.65 | 110.34 | 131.73 | 190.39 | 182.37 |
| Working Capital Days | 116.31 | 66.37 | 81.92 | 101.33 | 92.71 | 99.92 | 139.97 | 121.47 |
| ROCE % | 20.25% | 19.55% | 14.83% | 14.06% | 13.72% | 5.96% | 9.86% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.12 | 1.32 | 4.05 | 4.12 |
| Diluted EPS (Rs.) | 3.12 | 1.32 | 4.05 | 4.12 |
| Cash EPS (Rs.) | 3.49 | 1.66 | 4.72 | 4.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 43.95 | 41.03 | 40.01 | 36.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 43.95 | 41.03 | 40.01 | 36.63 |
| Revenue From Operations / Share (Rs.) | 108.54 | 88.54 | 126.85 | 125.95 |
| PBDIT / Share (Rs.) | 6.30 | 3.62 | 7.39 | 6.95 |
| PBIT / Share (Rs.) | 5.93 | 3.28 | 6.71 | 6.64 |
| PBT / Share (Rs.) | 4.34 | 1.85 | 5.61 | 5.72 |
| Net Profit / Share (Rs.) | 3.12 | 1.32 | 4.04 | 4.12 |
| NP After MI And SOA / Share (Rs.) | 3.12 | 1.32 | 4.05 | 4.12 |
| PBDIT Margin (%) | 5.80 | 4.08 | 5.82 | 5.52 |
| PBIT Margin (%) | 5.46 | 3.70 | 5.29 | 5.27 |
| PBT Margin (%) | 4.00 | 2.08 | 4.42 | 4.54 |
| Net Profit Margin (%) | 2.87 | 1.49 | 3.18 | 3.27 |
| NP After MI And SOA Margin (%) | 2.87 | 1.49 | 3.19 | 3.27 |
| Return on Networth / Equity (%) | 7.09 | 3.22 | 10.11 | 11.25 |
| Return on Capital Employeed (%) | 13.32 | 7.82 | 16.19 | 17.36 |
| Return On Assets (%) | 3.70 | 1.76 | 5.08 | 5.13 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.03 |
| Total Debt / Equity (X) | 0.42 | 0.40 | 0.31 | 0.33 |
| Asset Turnover Ratio (%) | 1.37 | 1.15 | 1.59 | 0.00 |
| Current Ratio (X) | 1.92 | 2.03 | 1.91 | 1.76 |
| Quick Ratio (X) | 0.93 | 1.17 | 1.30 | 1.25 |
| Inventory Turnover Ratio (X) | 3.22 | 2.94 | 4.98 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 6.41 | 22.70 | 16.06 | 15.76 |
| Dividend Payout Ratio (CP) (%) | 5.73 | 18.06 | 13.74 | 14.66 |
| Earning Retention Ratio (%) | 93.59 | 77.30 | 83.94 | 84.24 |
| Cash Earning Retention Ratio (%) | 94.27 | 81.94 | 86.26 | 85.34 |
| Interest Coverage Ratio (X) | 3.96 | 2.53 | 6.74 | 7.53 |
| Interest Coverage Ratio (Post Tax) (X) | 2.96 | 1.92 | 4.68 | 5.46 |
| Enterprise Value (Cr.) | 117.08 | 112.97 | 89.63 | 79.02 |
| EV / Net Operating Revenue (X) | 1.33 | 1.57 | 0.86 | 0.77 |
| EV / EBITDA (X) | 22.88 | 38.42 | 14.92 | 13.99 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.38 | 0.77 | 0.67 |
| Retention Ratios (%) | 93.58 | 77.29 | 83.93 | 84.23 |
| Price / BV (X) | 2.85 | 2.99 | 2.45 | 2.32 |
| Price / Net Operating Revenue (X) | 1.16 | 1.38 | 0.77 | 0.67 |
| EarningsYield | 0.02 | 0.01 | 0.04 | 0.04 |
After reviewing the key financial ratios for Mahickra Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.12. This value is below the healthy minimum of 5. It has increased from 1.32 (Mar 24) to 3.12, marking an increase of 1.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.12. This value is below the healthy minimum of 5. It has increased from 1.32 (Mar 24) to 3.12, marking an increase of 1.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.49. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 3.49, marking an increase of 1.83.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.95. It has increased from 41.03 (Mar 24) to 43.95, marking an increase of 2.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.95. It has increased from 41.03 (Mar 24) to 43.95, marking an increase of 2.92.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 108.54. It has increased from 88.54 (Mar 24) to 108.54, marking an increase of 20.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.30. This value is within the healthy range. It has increased from 3.62 (Mar 24) to 6.30, marking an increase of 2.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.93. This value is within the healthy range. It has increased from 3.28 (Mar 24) to 5.93, marking an increase of 2.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.34. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 4.34, marking an increase of 2.49.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.12. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 3.12, marking an increase of 1.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.12. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 3.12, marking an increase of 1.80.
- For PBDIT Margin (%), as of Mar 25, the value is 5.80. This value is below the healthy minimum of 10. It has increased from 4.08 (Mar 24) to 5.80, marking an increase of 1.72.
- For PBIT Margin (%), as of Mar 25, the value is 5.46. This value is below the healthy minimum of 10. It has increased from 3.70 (Mar 24) to 5.46, marking an increase of 1.76.
- For PBT Margin (%), as of Mar 25, the value is 4.00. This value is below the healthy minimum of 10. It has increased from 2.08 (Mar 24) to 4.00, marking an increase of 1.92.
- For Net Profit Margin (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 5. It has increased from 1.49 (Mar 24) to 2.87, marking an increase of 1.38.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 8. It has increased from 1.49 (Mar 24) to 2.87, marking an increase of 1.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.09. This value is below the healthy minimum of 15. It has increased from 3.22 (Mar 24) to 7.09, marking an increase of 3.87.
- For Return on Capital Employeed (%), as of Mar 25, the value is 13.32. This value is within the healthy range. It has increased from 7.82 (Mar 24) to 13.32, marking an increase of 5.50.
- For Return On Assets (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has increased from 1.76 (Mar 24) to 3.70, marking an increase of 1.94.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has increased from 0.40 (Mar 24) to 0.42, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.37. It has increased from 1.15 (Mar 24) to 1.37, marking an increase of 0.22.
- For Current Ratio (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.03 (Mar 24) to 1.92, marking a decrease of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 1. It has decreased from 1.17 (Mar 24) to 0.93, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.22. This value is below the healthy minimum of 4. It has increased from 2.94 (Mar 24) to 3.22, marking an increase of 0.28.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.41. This value is below the healthy minimum of 20. It has decreased from 22.70 (Mar 24) to 6.41, marking a decrease of 16.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.73. This value is below the healthy minimum of 20. It has decreased from 18.06 (Mar 24) to 5.73, marking a decrease of 12.33.
- For Earning Retention Ratio (%), as of Mar 25, the value is 93.59. This value exceeds the healthy maximum of 70. It has increased from 77.30 (Mar 24) to 93.59, marking an increase of 16.29.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.27. This value exceeds the healthy maximum of 70. It has increased from 81.94 (Mar 24) to 94.27, marking an increase of 12.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.96. This value is within the healthy range. It has increased from 2.53 (Mar 24) to 3.96, marking an increase of 1.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 3. It has increased from 1.92 (Mar 24) to 2.96, marking an increase of 1.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 117.08. It has increased from 112.97 (Mar 24) to 117.08, marking an increase of 4.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.33, marking a decrease of 0.24.
- For EV / EBITDA (X), as of Mar 25, the value is 22.88. This value exceeds the healthy maximum of 15. It has decreased from 38.42 (Mar 24) to 22.88, marking a decrease of 15.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.38 (Mar 24) to 1.16, marking a decrease of 0.22.
- For Retention Ratios (%), as of Mar 25, the value is 93.58. This value exceeds the healthy maximum of 70. It has increased from 77.29 (Mar 24) to 93.58, marking an increase of 16.29.
- For Price / BV (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has decreased from 2.99 (Mar 24) to 2.85, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.38 (Mar 24) to 1.16, marking a decrease of 0.22.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mahickra Chemicals Ltd:
- Net Profit Margin: 2.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 13.32% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.09% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.8 (Industry average Stock P/E: 94.26)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.42
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Plot No. 1209, Phase-3, GIDC Vatva, Ahmedabad Gujarat 382445 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Miteshkumar C Gandhi | Chairman & Managing Director |
| Mr. Ashishkumar C Gandhi | Whole Time Director |
| Mrs. Komal Miteshkumar Gandhi | Whole Time Director |
| Mrs. Amisha Shah | Independent Director |
| Mr. Niren Desai | Independent Director |
| Mrs. Basari Mehta | Independent Director |
FAQ
What is the intrinsic value of Mahickra Chemicals Ltd?
Mahickra Chemicals Ltd's intrinsic value (as of 03 January 2026) is ₹153.06 which is 2.04% higher the current market price of ₹150.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹121 Cr. market cap, FY2025-2026 high/low of ₹180/95.2, reserves of ₹28.48 Cr, and liabilities of ₹71.37 Cr.
What is the Market Cap of Mahickra Chemicals Ltd?
The Market Cap of Mahickra Chemicals Ltd is 121 Cr..
What is the current Stock Price of Mahickra Chemicals Ltd as on 03 January 2026?
The current stock price of Mahickra Chemicals Ltd as on 03 January 2026 is ₹150.
What is the High / Low of Mahickra Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mahickra Chemicals Ltd stocks is ₹180/95.2.
What is the Stock P/E of Mahickra Chemicals Ltd?
The Stock P/E of Mahickra Chemicals Ltd is 57.8.
What is the Book Value of Mahickra Chemicals Ltd?
The Book Value of Mahickra Chemicals Ltd is 45.1.
What is the Dividend Yield of Mahickra Chemicals Ltd?
The Dividend Yield of Mahickra Chemicals Ltd is 0.13 %.
What is the ROCE of Mahickra Chemicals Ltd?
The ROCE of Mahickra Chemicals Ltd is 9.86 %.
What is the ROE of Mahickra Chemicals Ltd?
The ROE of Mahickra Chemicals Ltd is 7.33 %.
What is the Face Value of Mahickra Chemicals Ltd?
The Face Value of Mahickra Chemicals Ltd is 10.0.